Symbol
| MAPK7
| contributors: mct - updated : 31-08-2018
|
HGNC name
| mitogen-activated protein kinase 7
|
HGNC id
| 6880
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
| deletion
|  
|  
|
in Smith-Magenis syndrome | tumoral
|  
| amplification
|  
|  
|
in hepatocellular carcinoma  | tumoral
|  
|  
| --over
|  
|
might contribute to ovarian cancer metastasis through up-regulating type II collagen expression ( might contribute to ovarian cancer metastasis through up-regulating type II collagen expression  | |
Variant & Polymorphism
other
|
| |
Candidate gene
Marker
| MAPK7 and MAP2K4 could be good markers in assessing response to treatment and development of osteosarcoma  | |
may be a new prognostic marker in clear cell renal cell carcinoma owing to its relationship with metastasis and more advanced stages  | Therapy target
| |
|
System | Type | Disorder | Pubmed |
cancer | digestive | liver |  |
cancer | bone | |  |
may be a new therapeutic target in invasive osteosarcoma expressing MMP9 | diabete | type 1 | |  |
may be a promising target for increasing beta-cell mass in diabetes patients | cardiovascular | cardiomyopathy | |  |
maintenance of cardiac MAPK7 is a therapeutic approach for cardiomyopathy prevention and/or treatment | cancer | reproductive | ovary |  |
may be a potential therapeutic target in the clinical treatment for ovarian cancer | immunology | inflammatory | |  |
is a potential therapeutic target in diverse disorders that cause inflammatory critical illness | cardiovascular | atheroma | |  |
Molecules that upregulate ERK5 and its signaling in macrophages may be good drug targets for suppressing cardiovascular diseases |
| |
| Erk4-deficient mice are viable and fertile and exhibit no gross morphological or physiological anomalies  | |
conditional deletion of the erk5 gene in mouse neural stem cells during development reduces the number of GABAergic interneurons in the main olfactory bulb (OB)  |